prof. dr Antonija Verhaz

GENOTYPING OF HEPATITIS C VIRUS IN INFECTED PATIENTS FROM REPUBLIKA SRPSKA

HIV disease metrics and COVID‐19 infection severity and outcomes in people living with HIV in central and eastern Europe

The status of hepatitis C microelimination among people living with HIV in Central and Eastern Europe in 2022-data from Euroguidelines in Central and Eastern Europe Network Group

Prevalence, clinical management, and outcomes of adults hospitalised with endemic arbovirus illness in southeast Europe (MERMAIDS-ARBO): a prospective observational study

Prevalence, clinical management, and outcomes of adults hospitalised with endemic arbovirus illness in southeast Europe (MERMAIDS-ARBO): a prospective observational study

Clinical and demographic characteristics of patients hospitalized for Influenza during the 2024/2025 season

Influenza in patients with chronic obstructive pulmonary diseases during the 2024/2025 season

The status of hepatitis C microelimination among people living with HIV in Central and Eastern Europe in 2022 - data from Euroguidelines in Central and Eastern Europe Network Group

The Outcome of Coronavirus Disease 2019 among People Living with HIV in European Union versus Non-European Union Countries

Evolution of hospitalized COVID-19 cases with emphasis on the first pandemic year: experience from the University Clinical Center of Republic of Srpska

Lyme neuroborreliosis in adults-epidemiology data and clinical findings.

The Study of Effi cacy and Safe of Lamivudine in Patients with Severe Acute Hepatitis B

Elimination of hepatitis C virus infection in hemodialysis patients in the Republic of Srpska: Small Group

PrEP Scale-Up and PEP in Central and Eastern Europe: Changes in Time and the Challenges We Face with No Expected HIV Vaccine in the near Future

HIV disease metrics and COVID‐19 infection severity and outcomes in people living with HIV in central and eastern Europe

Influenza-Associated Encephalitis and Encephalopathy

Abdominal Actinomycosis: Case Report

Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV—Data from ECEE Network Group

Clinical and Epidemiological Characteristics of Q Fever in Hospitalized in UCC Republic Srpska Banja Luka in 2016

Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV—Data from ECEE Network Group

Aspergiloza pluća kao komplikacija biološke terapije Covid-19infekcije kod imunokompromitovane pacijentice

Uticaj Covid-19 na strategiju prevencije i eliminacije hepatitisa B i hepatitisa C

Tocilizumab u terapiji Covid-19 infekcije-naša iskustva

The Presence of Either Typical or Atypical Radiological Changes Predicts Poor COVID-19 Outcomes in HIV-Positive Patients from a Multinational Observational Study: Data from Euroguidelines in Central and Eastern Europe Network Group

Antimicrobial resistance profiles of human Brucella melitensis isolates in three different microdilution broths: First multicentre study in Bosnia and Herzegovina

Tocilizumab u terapiji COVID19 infekcije-naša iskustva

The Management of HIV Care Services in Central and Eastern Europe: Data from the Euroguidelines in Central and Eastern Europe Network Group

Perzistentna Covid-19 ili reinfekcija kod pacijentkinje sa NHL (non-Hodgkin limfom)

The use of personal protective equipment by the employees in COVID-19 Departments of the University Clinical Center of Republic of Srpska and the risk assessment of the new coronavirus

Acute Pancreatitis in a Patient with COVID-19: A Case Report

Chronic Kidney Disease and Nephrology Care in People Living with HIV in Central/Eastern Europe and Neighbouring Countries—Cross-Sectional Analysis from the ECEE Network

Assessment of Autonomic Nervous System Dysfunction in the Early Phase of Infection With SARS-CoV-2 Virus

Retrospective evaluation of an observational cohort by the Central and Eastern Europe Network Group shows a high frequency of potential drug-drug interactions among HIV-positive patients receiving treatment for coronavirus disease 2019 (COVID-19)

The case series of 34 patients with COVID-19 diagnosed with HIV infection from Central and Eastern European Countries - Euroguidelines in Central and Eastern Europe Network Group data

The characteristics of HIV-positive patients with mild/asymptomatic and moderate/severe course of COVID-19 disease – a report from Central and Eastern Europe

Viral hepatitis in HIV-positive patients - testing, prophylaxis and treatment in Central and Eastern Europe

Where are we with pre‐exposure prophylaxis use in Central and Eastern Europe? Data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group

COVID-19 Pneumonia: When Negative RT-PCR Testing Does Not Rule out the Disease

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir Regimen in Haemodialysis Patients With Hepatitis C Virus Infection: A Case Series

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir ± Dasabuvir± Ribavirin in Treatment of Patients With Chronic Hepatitis C in the Republic of Srpska: a Real-Life Study

Karakteristike oboljelih od gripe hospitalizovanih u Klinici za infektivne bolesti Univerzitetskog kliničkog centra Republike Srpske u periodu od 01.01. do 31.03.2019.godine

Infectious mononucleosis in splenectomised patient

KARAKTERISTIKE OBOLJELIH OD GRIPE HOSPITALIZOVANIH U KLINICI ZA INFEKTIVNE BOLESTI UNIVERZITETSKOG KLINIČKOG CENTRA REPUBLIKE SRPSKE U PERIODU OD 01.01. DO 31.03.2019.GODINE

ACUTE INFLUENZA VIRUS-ASSOCIATED ENCEPHALITIS AND ENCEPHALOPATHY IN ADULTS

Karakteristike ospica danas

Tuberkulozni meningitis s tuberkuloznim granulomima u trudnoći – prikaz bolesnika

Varicella complications in the Clinic for Infectious Diseases UKC RS in a five-year period 2012-2016 years

Učestalost oksigenacionih poremećaja u cirozi jetre

Type I, II, and III Interferons: Regulating Immunity to Mycobacterium tuberculosis Infection

Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients: Results from the GUARD-C Cohort

Učestalost oksigenacionih poremećaja u cirozi jetre

Kliničke i epidemiološke karakteristike Q-groznice u hospitalizovanih bolesnika u UKC Republike Srpske tokom 2016

Type I, II, and III Interferons: Regulating Immunity to Mycobacterium tuberculosis Infection.

Hepatopulmonalni sindrom-često neprepoznata komplikacija u jetrenoj cirozi

Expirience with Lamivudine treatment severe acute hepatitis B

Diagnosis and Treatment of Chronic Viral Hepatitis B and C: Doctrinary Approach

Did pandemic preparedness aid the response to pandemic (H1N1) 2009? A qualitative analysis in seven countries within the WHO European Region

Akutni respiratorni distres sindrom kao komplikacija primarne Varicella Zoster virus infekcije kod trudnice

Fokalne lezije u jetri i hepatocelularni karcinom,

Rezistencija na antimikrobne lijekove kod infekcija urinarnog trakta nastalih zbog primjene urinarnih katetera

Kateterske urinarne infekcije u Kliničkom centru Banja Luka

I Kongres CUTIS (02.-04.10.2025.)

Significant discrepancies Between Clinical Practice and Medical Guidelines for HPV management in HIV - data from ECEE Network Group

Genotyping of hepatitis C virus in infected patients from Republika Srpska

Spolno prenosive bolesti u infektološkoj ambulanti

9th Euroguidelines in Central and Eastern Europe (ECEE) Conference in Warsaw, Poland, 13rd -14th June 2025.

14th Medical Conference of the Serbian Diaspora,

Optimizacija tretmana hepatocelularnog i karcinoma dojke

HIV Disease Metrics and COVID-19 infection severity and outcomes in People Living with HIV in Central and Eastern Europe

Both typical and atypical radiological changes predict poor COVID-19 outcome in HIV-positive patients from a multinational observational study – data from Euroguidelines in Central and Eastern Europe Network Group

Značaj hemokina CXCL13 u dijagnostici lajmske neuroborelioze

Title: The use of repurposed drugs for the treatment of COVID-19 in HIV patients – data from ECEE Network Group

Protokoli za dijagnozu i menadžment suspektnih i potvrđenih slučajeva COVID-19, primjena odgovarajućih javnozdravstvenih mjera i terapijski protokoli i nje

Comorbidities are the most important risk factor for poor outcome of COVID-19 among HIV-positive patients: data from Euroguidelines in Central and Eastern Europe Network Group

Regional Consultation for Developing Global Health Sector Strategies on HIV, Viral Hepatitis and STIs, 2022–2030

Viral hepatitis in HIV-positive patients – testing, prophylaxis and treatment in Central and Eastern Europe

Where are we with PrEP use in Central and Eastern Europe? – data from the ECEE Network Group

Suvremeni pristup liječenju kroničnog hepatitisa C u Republici Srpskoj / Contemporary approach to the treatment of chronic hepatitis C in Republic of Srpska

DISTRIBUCIJA GENOTIPOVA HEPATITIS C VIRUSA U REPUBLICI SRPSKOJ: DESETOGODIŠNJE RETROSPEKTIVNO ISKUSTVO

Savremeni pristup liječenju hroničnih hepatitisa C u Republici Srpskoj

Kliničke karakteristike i laboratorijski parametri od značaja kao prediktori ishoda oboljelih od gripe

Lajmska bolest: od uboda krpelja do dijagnoze i terapije

Krpeljski meningoencefalitis prikaz slučaja našeg pacijenta

Distribucija genotipova hepatitis C virusa u Republici Srpskoj: desetogodišnje retrospektivno iskustvo

LYME NEUROBORRELIOSIS - NAŠA ISKUSTVA

EFFICACY AND SAFETY OF OMBITASVIR/PARITAPREVIR/RITONAVIR ± DASABUVIR REGIMEN IN PATIENTS WITH SEVERE RENAL IMPAIRMENT WITH HCV GENOTYPE 1B INFECTION – CASE REPORT

Measles in healthcare workers in Banja Luka during the epidemic in 2018

Diferencijalna dijagnoza HGBS-a i leptospiroza

Karakteristike morbila danas

Rates of pregnancy and preterm birth in Central/Eastern Europe and neighboring countries – data from ECEE Networg Group

KOMPLIKACIJE VARIČELA U KLINICI ZA INFEKTIVNE BOLESTI UKC RS U ŠESTOGODIŠNJEM PERIODU 2012. – 2017. GODINE

Novosti u dijagnostici i liječenju Hepatitisa C

Efficasy and safety of ombitasvir/peritaprevir/ritonavir+ dasabuvir+ ribavirin in patients treated at the Clinic for infectious diseases, republica Srpska Banja Luka

Aktuelne virusne infekcije, Trebinje,Simpozijum aktuelne virusne infekcije

Efficacy and safety of ombitasvir/paritaprevir/ritonavir + dasabuvir treatment of hepatitis C patients in Republic of Srpska

Interferon free terapija u liječenju oboljelih od hroničnog hepatitisa c - naša iskustva

Did you win hepatitis C?

Terapija hroničnog hepatitisa C-monitoring virusološkog odgovora

Lamivudine u liječenju teških oblika akutnog hepatitisa B

Lamivudine in acute severe hepatitis B

Upala pluća kao jedan od razloga hospitalizacije pacijenata sa febrilnim stanjem u Klinici za infektivne bolesti i terapijski pristup

Lamivudine treatment for acute severe hepatitis

Abdominalna aktinomikoza: prikaz slučaja

Problem antimikrobne rezistencije kateterskih urinarnih infekcija u KC Banja Luka

The problem of Antimicrobial Resistance to Catheter Associated Urinary Tract Infections in Clinical Center of Banja Luka

Izvještaj o kliničkom i serološkom praćenju bruceloze kod ljudi od 1984. do 2005. godine

Antibiotic Resistance in Catheter-Associated Urinary Infections at the Clinical Center of Banja Luka - Bosnia and Herzegovina

Tularemia-clinical features and new signs

Iskustva i problemi u radu na postekspozicijskoj antirabičnoj zaštiti u ratnim uslovima

Hemoragična groznica sa bubrežnim sindromom kao ratna zaraza pripadnika Vojske Republike Srpske

Klinički oblici i liječenje tularemije kod oboljelih iz ratnih područija

STAV EKPERTNE GRUPE STRUČNOG VIJEĆA O ULOZI LIJEKA ISOPRINOSINE® U LIJEČENJU AKUTNIH RESPIRATORNIH VIRUSNIH INFEKCIJA (ARVI) UKLJUČUJUĆI GRIPU i COVID-19

7th Euroguidelines in Central and Eastern Europe (ECEE) Conference “The Future of HIV and Hepatitis in Central and Eastern Europe”

COVID – 19 klinička slika i terapijski izazovi

Liječenje sepse u trudnoći i puerperiju

ERI-HEALTH-Public Health Preparedness for Cross-border Epidemics and Emergencies. Protocols for the diagnosis and management of suspected and confirmed cases of COVID-19, the application of appropriate public health measures and therapeutic protocols and care of patients at the primary level, including the rational use of antibiotics

Projekt Weeri Stage I 2023 Project: Reviewing Screening Practices and Management of Latent Tubercullosis Infection in HIV patients from Central and Eastern Europe

Effective direct-acting antiviral treatments in an effort to eliminate hepatitis C in Republic of Srpska

PRESCRIBING OF ABs: paterns before and during the pandemic

HCV co-infection in person living with HIV infection in Republic of Srpska

The use of unproven drugs for COVID-19 treatment in people living with HIV.

Life Beyond HIV

Comorbidities are the most important risk factor for poor outcome of COVID-19 among HIV-positive patients: data from Euroguidelines in Central and Eastern Europe Network Group

“HIV and Hepatitis in Times of Multiple Challenges”

,Epidemiološki nadzor i kontrola infekcije COVID-19

»Prema eliminaciji virusnih hepatitisa«

IZLIJEČENJE HEPATITISA C – MIKROELIMINACIJA U HEMODIJALIZNIM CENTRIMA

Savjetodavni odbor Mjesto novog oralnog proteaznog inhibitora SARS-CoV-2 u LIJEČENJU COVID-19

THe Experts

ERI-HEALTH –Public Health Preparedness for Cross-border Epidemics and Emergencies

Šta je lijek tridekaktid i metenkefalin (ENKORTEN®), mehanizam djelovanja u farmakoterapiji COVID 19, kada treba dati tridekaktid i metenkefalin (ENKORTEN®)?

Peti simpozijum o bolestima zavisnosti sa međunarodnim učešćem "Sistemski odgovor na bolesti zavisnosti"

Izazovi pandemije COVID-19 ‒ gdje se nalazimo danas i kako dalje?

Mentrostvo:;“ Razlike o informiranosti i stavovima o cijepljenju djece između zdravstvenih radnika i opšte populacije“

Alfalipoinska kiselina u prevenciji i terapiji virusnih infekcija - PROTECT Kontrol

„Infekcija COVID-19 nakon cijepljenja: iskustva u UKC Republika Srpska Banja Luka“

Liječenje PWID populacije

Savremena terapija HCV

Šta smo naučili o COVID-19

Hepatitis C virtualna radionica

Primjena antioksidanasa u kardiovaskularnoj i neurovaskularnoj prevenciji

HCV regionalni meeting Gilead

HEPATIS C – KORAK U BUDUĆNOST

Novosti u liječenju Covid19

Otvoreno, prospektivno, randomizirano, komparativno kliničko ispitivanje efikasnosti i sigurnosti lijeka ENKORTEN® kao imunomodulatorne terapije u okviru uobičajenog, terapijskim protokolom utvrđenog, liječenja pacijenata sa srednje teškim i teškim oblikom COVID‐19 infekcije

Priručnik za liječenje infekcije izazvane novim virusom korona

Šta smo naučili o COVID-19?

HCC – an avoidable fate: To Liver Cancer Prevention by Viral Hepatitis Elimination (and beyond) trough Universal Health Coverage with additional reference to COVID-19

HCV Elimination Advisory Board in Belgrade, on 21st May 2019.

HIV i HCV tretman i komunikacijske vjestine

Beyond Science Meeting

HCV exCHANGE

Savremena terapija HCV-a: Lijecenje HCV-a za 8 sedmica

3rd Euroguidelines in Central and Eastern Europe (ECEE) Conference Prevention and care for HIV and Hepatitis

European Virology Meeting HIV&HCV: from clinical trials to real world data-too soon to rest?

Savremena HCV terapija, LDV/SOF u terapiji HCV-a

Screening and prevention for viral hepatitis and HIV in CEE comon challenges,joint solutions

Novosti u gastroenterologiji, simpozij gastroenterologa

Reѕervni Član komisije za odbranu magistarskog rada

4TH MEETING OF THE HEPATITIS B AND C NETWORK EMCDDA

koordinatora specijalizacija za infektologiju

„Preporuke za liječenje hepatitisa C u R.Hrvatskoj i zemljama ADRIA regije-osvrt na EASL preporuke“

Molekularni, klinički i epidemiološki aspekti humane bruceloze u B&H“, koja bi pratila izolate Brucella spp iz hemokultura u BIH.

„Liječenje HCV pacijenata sa dekompenzovanom cirozom jetre“

„Urgentna infektološka stanja u radu ljekara porodične/obiteljske medicine“

Recenzent u časopisu Medicinski glasnik

tranzijentnu elastografiju (FibroScen)

„Molekularni, klinički i epidemiološki aspekti humane bruceloze u B&H“.

smjernica dobre kliničke prakse „Teška sepsa i septički šok“

Mentorstvo kandidata za završni rad prvog ciklusa

član konzilijuma za hepatitise RS

Multi-centre EuRopean study of Major Infectious Diseases Syndromes- Arboviral compatible febrile illness

Liječenje oboljelih sa koinfekcijama: Hepatitis B i C i HIV.; Tuberkuloza i HIV

Kliničke vodilje za tretman HIV-a i AIDS-a u Bosni i Hercegovini

HCV2020 Forum 2016

2nd Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV

„Multi-country antimicrobial resistance workshop“

član u komisiji za javno zdravstvo

Član komisije za odbranu rada drugog ciklusa

rani pristup lijeku 3D režimom (250 mg dasabuvir i 12.5mg /75mg/50mg ombitasvir/paritaprevir/ritonavir) za hronični hepatitis C

„Regionalne tehničke konsultacije SZO, globalnog zdravstvenog sektora za startegiju HIV-a, virusnih hepatitisa i seksualno transmisivnih infekcija“

Liječenje koinfekcija i inovativni pristup u prevenciji HIV-a

Global Observational Cohort Study on the Prediction of Unwanted Adverse Effects in Individuals Infected with Chronic Hepatitis C Receiving a Long-Acting Interferon plus Ribavirin (GUARD-C)

A Multicenter, Prospective, Observational, Non-Interventional Cohort Study Evaluating On-Treatment Predictors of Response in Subjects with HBeAg positive or HBeAg negative Chronic Hepatitis B Receiving Therapy with PEGASYS® (Peginterferon alfa-2a 40KD).

HIV i visoko rizična zanimanja

Mentorstvo kandidata za stepen drugog ciklusa

Član komisije za ocjenu magistarskog rada

mentorstvo kandidata za drugi stepen ciklusa

člana komisije za lijekove i medicinska sredstva BiH

Rani skrining i dijagnostikovanje virusnih hepatitisa B i C u Republici Srpskoj

Multisektorski odgovor na bolesti zavisnosti

2ND MEETING OF THE HEPATITIS B AND C NETWORK

Član komisije za polaganje specijalističkog ispita

Latent Tuberculosis Infection (LTBI) prevalence among high risk health professionals infectious and pulmology clinics in B&H and LTb, HIV/AIDS and Hepatitis C screening prevalence among MSM population- A pilot/project study

monotematskoj konferenciji vazanu za razvoj novih pravaca u liječenju hepatitisa C

člana u komisiji za kontrolu zaraznih bolesti u RS

1st Global Workshop on HCV Therapy on HCV Advances

ERI-HEALTH –Public Health Preparedness for Cross-border Epidemics and Emergencies

Protokol za dijagnostiku i liječenje Hronične Hepatitis C virusne infekcije u Republici Srpsko

nacionalnog koordinatora za hepatitise Republike Srpske

„Povećanje univerzalnog pristupa za populacije pod rizikom u Bosni i Hercegovini

COVID – 19 klinička slika i terapijski izazovi

Hronični virusni hepatitis C

KLINIČKE VODILJE ZA TRETMAN HIV-a I AIDS-

Osnove kliničke onkologije sa radioterapijom

Dijagnostičko-terapijski vodič za hronični hepatitis B i C

Infektologija